NEWS & EVENTS
THE LATEST ON PMT
Oxylator Resuscitation Device Safely Used on Patient with COVID-19
April 13, 2020, Hallandale, Florida – PMT Partners announced today the Oxylator®, a small compact patient-responsive portable resuscitation – ventilation device, was safely used to treat a patient with COVID-19 pneumonia in the intensive care unit (ICU).
“The Oxylator provided swift preoxygenation to facilitate deep sedation on a patient with COVID-19 pneumonia in the ICU,” said James DuCanto, M.D., Anesthesiologist Milwaukee, Wisconsin USA who has experience using the Oxylator in resuscitation and routine anesthetic care. “A tight two-handed mask seal ventilation technique was used with the device in ‘automatic mode’ to minimize potential spread of aerosolized droplets. The device then supported ventilation while the respiratory therapist readied the ventilator for longer-term respiratory care.”
Oxylators are oxygen powered resuscitation/inhalation devices, no electricity required. Oxygen, air, or a combination thereof can be delivered through the Oxylator to provide optimum care to patients requiring acute respiratory support. Oxylators may simplify airway management during emergencies and attended short-term ventilation during surge ventilation events.
“The Oxylator in ‘automatic mode’ effectively requires the patient to inhale to set pressure,” continued Dr. DuCanto. “This enhances lung recruitment, maintains an open oropharyngeal airway, and causes the washout of Nitrogen at a pace that I have not seen with other devices.”
The Oxylator was also designed to facilitate optimal airway management when the operator is free to utilize two hands during mask ventilation and simplify ongoing ventilation with supraglottic airways or tracheal tubes during static care or during active patient transport.
“Clinicians are sharing new ways to treat patients with COVID-19 on a daily basis,” said Larry Kronick, President of PMT Partners who distributes the Oxylator. “Hospitals and clinicians need a variety of tools to treat diverse patient needs. We look forward to more patient success stories.”
Oxylator demonstration video links:
Simulated mass casualty video link:
PMT Partners is a private medical device company that designs, develops, commercializes, and distributes technologies to improve patient care. Products available from PMT Partners include the Oxylator, PowrSyringe Angiographic Injector, and the AirTight Control Syringe.
PMT Partners Media Contact:
AirTight Control Syringe Cleared for Sale
PMT Partners announced that the FDA and CE-Mark cleared AirTight Control Syringe was approved for sale, and the company began shipping product on August 14, 2019. The AirTight Control Syringe is intended to inject contrast media or saline during angiographic procedures and offers substantial improvements in injection ergonomics and patient safety as compared to fixed and rotating-luer control syringes commonly used for angiographic injection today.
While fixed-luer syringes offer secure, leak-free connections to catheters and manifolds, their solid, one-piece design makes this connection and disconnection awkward for clinicians.
Rotating-luer syringes have an integrated O-ring design that makes them easier to connect and disconnect, but they are prone to loose, wobbly connections and air leakage, putting patients at risk of air embolism.
The patented AirTight Syringe Control Syringe bridges the gap between fixed and rotating luer angiographic control syringes, offering easy connection and disconnection to catheters and manifolds without compromising patient safety.
PMT Partners' AirTight Platform is protected by U.S. patents 10,207,057; 10,058,656; and other U.S. and foreign pending and issued patents.
For more information about PMT Partners and the company's AirTight Platform, call 1-954-534-9345 or visit www.powrsyringe.com.